Investors in Art

New Renaissance Ventures is the premier VC-brand investing in technology-driven startups built by top-tier entrepreneurs in Visual Arts, Performing Arts, New Media and Cultural Heritage. They back the next generation of cultural leaders in their earliest stages.

OÖ Hightech Fund aims to make Upper Austria even more attractive as a business location for high-technology-oriented, innovative companies and to offer development opportunities for the high potentials and economic engines of tomorrow. They invest in local start-ups and SMEs that develop and market products and services in the high-tech sector.

Overkill Ventures invests in pre-seed stage startups and helps them get to product-market fit. They are mainly focusing on the Baltics, Nordics, CEE & CIS.

Investment is about building the future that lies ahead. Their investment opportunities are focused on AI because it drives the future of how machines, data, and technologies are being programmed. By channeling their deep domain expertise into identifying investment opportunities, they back AI companies with high potential to impact conventional industries or society.

They invest in early-stage technology companies driving building innovation and energy transition. They finance and support startups and scaleups that enhance building intelligence, energy efficiency, safety, and comfort. As an open-ended ‘evergreen fund,’ they focus on long-term value and impact. They serve as an ecosystem for their investors and portfolio companies, offering the expertise, network, and capital necessary to help achieve their goals.

They accelerate growing startups. There is a missing opportunity between a successful start and achieved milestones. ScaleFund’s mission is to bridge this equity gap and boost promising companies.

Lumiares proactively pursues the most promising digital health opportunities which it funds and supports from the incubation phase onwards. In addition to its internal team, it leverages a strong network of external clinical, technological and business experts to validate innovative digital health solutions and accelerate their time-to-market. Lumiares helps them develop a strong value proposition and scalable business model with clear benefits to patients, care givers and payers.

They invest in early stage B2B SaaS, prioritizing partnerships with strong founding teams that demonstrate initial traction. They can do tickets from €300K up to €2M and generally move fast. Hands-on when asked, sharing advice when needed, understanding when it is decided to ignore it all.

BAF is a venture capital firm which invests in startups, early stage companies and SMEs in Baltic region. Business Angel Fund's investment size varies between 50k and 600k EUR. BAF invests along with Business Angels same conditions .

Coinvest Capital invests in start-ups and companies undergoing business development and growth with groups of business angels.

PMV provides venture capital – always in co-financing with the market – both at an early stage and to more mature companies. This may range from limited tickets – often in as convertible subordinated loans – to large capital tickets. PMV is different from many other capital providers. It has no pre-determined exit date and can therefore spend years working with your company to build its future. Moreover, it is an active but patient investor. PMV will try to meet your financing needs in the best possible way, taking into account both your needs and those of other stakeholders.

Wellstreet Ventures' Ventures II Fund continues their successful approach from their first fund, targeting early-stage startups in D2C, B2B, SaaS, and product sectors. They prioritize diverse founders with strong commercial acumen and a growth mindset. Key investment criteria include enhancing customer experience, utilizing data-driven models, and adhering to proactive ESG standards. They focus on startups poised for mainstream adoption, ensuring strategic early-stage investments.